14
Participants
Start Date
September 20, 2019
Primary Completion Date
October 31, 2019
Study Completion Date
October 31, 2019
Treatment A
Subject will be given AZD5718 Dose A tablet once daily
Treatment B
Subjects will be given AZD5718 Dose B tablet once daily
Treatment C
Subjects will be given AZD5718 Dose C tablet once daily
Research Site, London
Lead Sponsor
Collaborators (1)
Parexel
INDUSTRY
AstraZeneca
INDUSTRY